CoChat

Mass spectrometry, immunoassay and valid steroid measurements in reproductive medicine and science

Open access
Handelsman, David J. · 2017 · Human Reproduction
Cited by 59

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

In this issue of Human Reproduction, three related Letters to the Editor appear. The first from Keelan et al. objects that testosterone measurements in cord serum reported by Liu et al. (2016) using a direct (non-extraction) testosterone immunoassay are inaccurate relative to the gold standard of mass spectrometry (MS)-based steroid measurements in cord serum, citing their thorough review of biological and analytical factors impacting on cord serum testosterone and estradiol measurement (Hollier et al., 2014). Liu et al. defend the use of a direct testosterone immunoassay with several arguments. A third letter from Warembourg et al. (2016), authors of another paper who also used a direct testosterone immunoassay for measurement in cord serum, concede that they used a convenient, available method but one which they now recognize is unsound and would no longer use. To understand why Keelan et al. are right but Liu et al. are mistaken while Warembourg et al. are on the right track, requires some background on measuring steroids in biological fluids. Accurate, sensitive measurement of steroids in biological fluids is a fundamental pillar of mechanistic understanding in modern reproductive biology and medicine. During the early 20th century, the original quantitative method to measure sex steroids was whole animal in vivo bioassays which were pivotal in guiding purification of all major steroid classes by the mid-1930s. These in vivo bioassays were, nevertheless, cumbersome, laborious and insensitive and therefore impractical for application to medicine although they continue to have important uses in contemporary regulatory pharmacology and toxicology (Marty and O'Connor, 2014). Whole animal in vivo steroid bioassays were superseded by the revolutionary invention of immunoassay in 1959 (Yalow and Berson, 1959, 1960) marking the birth of modern Endocrinology. This powerful innovation had a formative impact that quickly rippled through all biological disciplines, notably pathology as well as reproductive biology and medicine. Virtually all disciplines touched by immunoassay flourished in the light of newfound ability to measure, with exquisite simplicity and unprecedented sensitivity, low levels of bioactive molecules in biological tissues, orders of magnitude lower than was possible with the traditional in vivo whole animal bioassays. Since its inception, the great and durable niche for immunoassay has been its application to measurement of large, immunogenic peptides for which, even now, purely chemical methods are still only emerging as research tools (Woldemariam and Butch, 2014). Immunoassays depend on an antibody generated against the target analyte but with epitope specificity that is inherently uncontrollable so that specificity limitations dependent on the antibody cannot be fully eradicated. Consequently, immunoassays differ from other analytical chemical methods (e.g. haemoglobin, creatinine or cholesterol), which are much easier to standardize universally using commonly available reagents. However, the application of immunoassay to non-immunogenic small molecules like steroids was delayed by a decade (Abraham, 1969; Furuyama et al., 1970) because additional methods had to be developed not only to create antibodies to non-immunogenic small molecules but also to ensure specificity of the resulting immunoassays. The development of antibodies was achieved by chemical conjugation of steroids to larger immunogenic haptens as carriers. A key caveat was that the antibody generated would remain ‘blind’ to the conjugation site on the steroid, creating the molecular basis for cross-reactivity with structurally related steroids. Furthermore, the innovators recognized that steroid immunoassay validity depended critically on pre-assay separation of numerous steroid precursors and metabolites structurally related to the target analyte as well as removing non-specific matrix interference in antigen-antibody and subsequent analytical reaction, crucial steps achieved by organic solvent extraction and chromatography. Hence the pioneering, in-house steroid immunoassays of the 1970–1980s featured the triplet validity criteria for steroid immunoassays—solvent extraction, chromatography and authentic (tritiated or C14 labelled) steroid tracers—so that their findings using such fastidious methodology remain valid today. However, soon the revelations from steroid immunoassays were so striking that demands grew rapidly for their application for use in medical care. This lucrative market opportunity led to a drive for incorporating steroids into multiplex immunoassay platforms (and corresponding single tube kits for research labs). These simplified methods aim to automate measurement steroids in unprocessed human serum/plasma and have come to dominate chemical pathology and research labs over recent decades whereas the original laborious manual steroid immunoassays disappeared from all but large US commercial pathology companie

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/dex078

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Handelsman, D. J.
Venue
Human Reproduction
Published
2017-04-27
Volume
32
Issue
6
Pages
1147-1150
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2610090351
Cited by
59
References
9
FWCI
3.09
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.